Zobrazeno 1 - 10
of 4 219
pro vyhledávání: '"Treilleux I"'
Autor:
Mery B, Ménétrier-Caux C, Montané L, Heudel PE, Ray-Coquard I, Bachelot T, Derbel O, Augereau P, Treilleux I, Berthet J, Nkodia A, Bardin-Dit-Courageot C, Attignon V, Ferrari A, Garin G, Perol D, Caux C, Dubois B, Trédan O
Publikováno v:
Breast Cancer: Targets and Therapy, Vol Volume 15, Pp 311-325 (2023)
Benoîte Mery,1,2,* Christine Ménétrier-Caux,2,3,* Laure Montané,4 Pierre-Etienne Heudel,1 Isabelle Ray-Coquard,1 Thomas Bachelot,1 Olfa Derbel,5 Paule Augereau,6 Isabelle Treilleux,2,7 Justine Berthet,2,3 Axelle Nkodia,3 Christine Bardin-
Externí odkaz:
https://doaj.org/article/395c31f0ef574d4988df3a9d47ac221c
Publikováno v:
In Ultrasonics August 2021 115
Autor:
El Sabeh R, Bonnet M, Le Corf K, Lang K, Kfoury A, Badran B, Hussein N, Virard F, Treilleux I, Le Romancer M, Lebecque S, Manie S, Coste I, Renno T
Publikováno v:
Journal of Inflammation Research, Vol Volume 14, Pp 2149-2156 (2021)
Rana El Sabeh,1,2 Mélanie Bonnet,1 Katy Le Corf,1 Kevin Lang,1 Alain Kfoury,1 Bassam Badran,2 Nader Hussein,2 Francois Virard,1 Isabelle Treilleux,3 Muriel Le Romancer,1 Serge Lebecque,1 Serge Manie,1 Isabelle Coste,1,* Toufic Renno1,* 1Université
Externí odkaz:
https://doaj.org/article/90eaabc436da402b9b0ebd6a84d177d0
Autor:
Virard F; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France.; University of Lyon, Faculté d'Odontologie, Hospices Civils de Lyon, Lyon, France., Giraud S; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France.; Center for Drug Discovery and Development, Synergy Lyon Cancer Foundation, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France., Bonnet M; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France., Magadoux L; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France., Martin L; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France.; Center for Drug Discovery and Development, Synergy Lyon Cancer Foundation, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France., Pham TH; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France., Skafi N; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France., Deneuve S; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France., Frem R; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France., Villoutreix BO; Université de Paris, NeuroDiderot, Inserm, Hôpital Robert Debré, 75019, Paris, France., Sleiman NH; Institut de Génomique Fonctionnelle de Lyon, UMR 5242-CNRS/ENSL, Université Claude Bernard Lyon 1, Lyon, France., Reboulet J; Institut de Génomique Fonctionnelle de Lyon, UMR 5242-CNRS/ENSL, Université Claude Bernard Lyon 1, Lyon, France., Merabet S; Institut de Génomique Fonctionnelle de Lyon, UMR 5242-CNRS/ENSL, Université Claude Bernard Lyon 1, Lyon, France., Chaptal V; Drug Resistance & Membrane Proteins group, Molecular Microbiology and Structural Biochemistry Laboratory (CNRS UMR 5086), University of Lyon, Lyon, France., Chaveroux C; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France., Hussein N; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France., Aznar N; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France., Fenouil T; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France.; University of Lyon, Faculté de Médecine, Hospices Civils de Lyon, Lyon, France., Treilleux I; Pathology Department, Centre Léon Bérard, Lyon, France., Saintigny P; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France., Ansieau S; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France., Manié S; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France., Lebecque S; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France.; University of Lyon, Faculté de Médecine, Hospices Civils de Lyon, Lyon, France., Renno T; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France. toufic.renno@lyon.unicancer.fr., Coste I; University Claude Bernard Lyon 1, INSERM U1052-CNRS UMR5286, Lyon Cancer Research Center, Centre Léon Bérard, Lyon, France. isabelle.coste@lyon.unicancer.fr.
Publikováno v:
Nature communications [Nat Commun] 2024 Aug 15; Vol. 15 (1), pp. 7037. Date of Electronic Publication: 2024 Aug 15.
Autor:
Derquin, F., Floquet, A., Hardy-Bessard, A.C., Edeline, J., Lotz, J.P., Alexandre, J., Pautier, P., Angeles, M.A., Delanoy, N., Lefeuvre-Plesse, C., Cancel, M., Treilleux, I., Augereau, P., Lavoue, V., Kalbacher, E., Berton Rigaud, D., Selle, F., Nadeau, C., Gantzer, J., Joly, F., Guillemet, C., Pomel, C., Favier, L., Abdeddaim, C., Venat-Bouvet, L., Provansal, M., Fabbro, M., Kaminsky, M.C., Lortholary, A., Lecuru, F., Coquard, I. Ray, de La Motte Rouge, T.
Publikováno v:
In Gynecologic Oncology September 2020 158(3):666-672
Autor:
Lenck, C., Chopin, N., Gouy, S., Bonsang-Kitzis, H., Martinez-Gomez, C., Radosevic-Robin, N., Martin, S., Lefeuvre-plesse, C., Lambaudie, E., Leblanc, E., Guyon, F., Classe, J.-M., Ramanah, R., Beurrier, F., Angeles, M.A., Pomel, C., Joly, F., de la Motte Rouge, T., Provansal, M., Lesoin, A., Floquet, A., Berton, D., Kalbacher, E., Chakiba, C., Meeus, P., Selle, F., Treilleux, I., Lecuru, F., Pautier, P., Ray-Coquard, I.
Publikováno v:
In Gynecologic Oncology April 2020 157(1):78-84
Autor:
Vanacker H; Centre Léon Bérard, Lyon, France., Treilleux I; Centre Léon Bérard, Lyon, France., Schiffler C; Centre Léon Bérard, Lyon, France., Bieche I; Institut Curie, Paris, France., Campone M; Institut de cancérologie de l'ouest Pays de Loire Nantes-Angers, Saint-Herblain, France., Patsouris A; Institut de cancérologie de l'ouest Pays de Loire Nantes-Angers, Saint-Herblain, France., Arnedos M; Gustave Roussy, Villejuif, France., Cottu PH; Institut Curie, Paris, France., Jacquin JP; Institut de Cancérologie Lucien Neuwirth, Saint-Priest-En-Jarez, France., Dalenc F; ICR, Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France., Pinton A; Institut Curie, Paris, France., Servant N; Institut Curie, Paris, France., Attignon V; Centre Léon Bérard, Lyon, France., Rouleau E; Gustave Roussy, Villejuif, France., Morel A; Institut de cancérologie de l'ouest Pays de Loire Nantes-Angers, Saint-Herblain, France.; Univ Angers, Nantes Université, Inserm, CNRS, CRCI2NA, SFR ICAT, F-49000, Angers, France., Legrand F; UNICANCER R&D, Paris, France., Jimenez M; UNICANCER R&D, Paris, France., Andre F; Gustave Roussy, Villejuif, France., Bachelot T; Centre Léon Bérard, Lyon, France. thomas.bachelot@lyon.unicancer.fr.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Mar; Vol. 130 (4), pp. 613-619. Date of Electronic Publication: 2024 Jan 05.
Autor:
Le Saux O; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Centre Léon Bérard, 69008, Lyon, France., Ardin M; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France., Berthet J; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France., Barrin S; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France., Bourhis M; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France., Cinier J; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France., Lounici Y; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France., Treilleux I; Department of Anatomopathology, Centre Léon Bérard, 69008, Lyon, France., Just PA; Department of Anatomopathology, AP-HM, Marseille, France., Bataillon G; Department of Anatomopathology, University hospital of Toulouse, Toulouse, France., Savoye AM; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Institut Jean Godinot, Reims, France., Mouret-Reynier MA; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France., Coquan E; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Centre François Baclesse, Caen, France., Derbel O; Department of Medical Oncology, Hôpital Privé Jean Mermoz, Lyon, France., Jeay L; Keen Eye Technologies-Paris, France, now Tribun Health, Paris, France., Bouizaguen S; Keen Eye Technologies-Paris, France, now Tribun Health, Paris, France., Labidi-Galy I; Department of Oncology, Hôpitaux universitaires de Genève, Faculty of Medecine, Center of Translational Research in Onco-Hematology, Swiss Cancer Center Leman, Geneva, Switzerland., Tabone-Eglinger S; Human Biological Resources, Centre Léon Bérard, 69008, Lyon, France., Ferrari A; Synergie Lyon Cancer, Gilles Thomas Bioinformatics Platform, Centre Léon Bérard, CEDEX 08, F-69373, Lyon, France., Thomas E; Synergie Lyon Cancer, Gilles Thomas Bioinformatics Platform, Centre Léon Bérard, CEDEX 08, F-69373, Lyon, France., Ménétrier-Caux C; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France., Tartour E; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France., Galy-Fauroux I; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France., Stern MH; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) Team, Institut Curie, PSL Research University, 75005, Paris, France., Terme M; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France., Caux C; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France., Dubois B; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France. bertrand.dubois@lyon.unicancer.fr.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France. bertrand.dubois@lyon.unicancer.fr.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France. bertrand.dubois@lyon.unicancer.fr., Ray-Coquard I; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France. isabelle.ray-coquard@lyon.unicancer.fr.; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France. isabelle.ray-coquard@lyon.unicancer.fr.; Department of Medical Oncology, Centre Léon Bérard, 69008, Lyon, France. isabelle.ray-coquard@lyon.unicancer.fr.
Publikováno v:
Nature communications [Nat Commun] 2024 Jul 16; Vol. 15 (1), pp. 5932. Date of Electronic Publication: 2024 Jul 16.
Autor:
Ray-Coquard IL; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Centre Léon Bérard, University Claude Bernard, Lyon, France. isabelle.ray-coquard@lyon.unicancer.fr., Savoye AM; GINECO and Institut Jean Godinot, Reims, France., Schiffler C; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Centre Léon Bérard, University Claude Bernard, Lyon, France., Mouret-Reynier MA; GINECO and Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France., Derbel O; GINECO and Institut de Cancérologie, Hôpital Privé Jean Mermoz, Lyon, France., Kalbacher E; GINECO and Centre Hospitalier Universitaire Jean Minjoz, Besançon, France., LeHeurteur M; GINECO and Medical Oncology Department, Centre Henri-Becquerel, Rouen, France., Martinez A; GINECO and Institut Claudius Régaud, Institut Universitaire du Cancer de Toulouse (IUCT) Oncopole, Toulouse, France., Cornila C; GINECO and Centre Hospitalier Régional d'Orléans, Orleans, France., Martinez M; GINECO and Clinique Pasteur, Toulouse, France., Bengrine Lefevre L; GINECO and Centre Georges-François Leclerc, Dijon, France., Priou F; GINECO and Centre Hospitalier Départemental Vendée, La Roche-Sur-Yon, France., Cloarec N; GINECO and Centre Hospitalier Henri Duffaut d'Avignon, Avignon, France., Venat L; GINECO and Centre Hospitalier Universitaire Dupuytren, Limoges, France., Selle F; GINECO and Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France., Berton D; GINECO and Institut de Cancérologie de l'Ouest, Centre René Gauducheau, Saint-Herblain, France., Collard O; GINECO and Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez, France.; Center of Medical Oncology, Hôpital Privé de la Loire, Saint-Etienne, France., Coquan E; GINECO and Department of Medical Oncology, Centre François Baclesse, University Caen Normandie, Caen, France., Le Saux O; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Centre Léon Bérard, University Claude Bernard, Lyon, France.; Cancer Research Center of Lyon (CRCL), UMR INSERM 1052, Centre Léon Bérard, CNRS 5286, Lyon, France., Treilleux I; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Centre Léon Bérard, University Claude Bernard, Lyon, France., Gouerant S; GINECO and Medical Oncology Department, Centre Henri-Becquerel, Rouen, France., Angelergues A; GINECO and Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France., Joly F; GINECO and Department of Medical Oncology, Centre François Baclesse, University Caen Normandie, Caen, France., Tredan O; GINECO and Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
Publikováno v:
Nature communications [Nat Commun] 2024 Jul 16; Vol. 15 (1), pp. 5931. Date of Electronic Publication: 2024 Jul 16.
Autor:
Chiannilkulchai, N., Pautier, P., Genestie, C., Bats, A.S., Vacher-Lavenu, M.C. †, Devouassoux-Shisheboran, M., Treilleux, I., Floquet, A., Croce, S., Ferron, G., Mery, E., Pomel, C., Penault-Llorca, F., Lefeuvre-Plesse, C., Henno, S., Leblanc, E., Lemaire, A.S., Averous, G., Kurtz, J.E., Ray-Coquard, I. *
Publikováno v:
In Annals of Oncology June 2017 28(6):1274-1279